MRNA vs RDIB · rev $145.0M vs rev $112.0M
Moderna Inc (MRNA) versus Reading International B Inc (RDIB) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Reading International B Inc (RDIB) is a entertainment company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported RDIB revenue for 2026-06-30 was $112.0M. Net income was -$5.9M. RDIB currently screens at market cap $211.3M.
MRNA currently screens at market cap $24.52B. RDIB currently screens at market cap $211.3M.
Not investment advice. Open the MRNA and RDIB stock pages for the full models.
Not investment advice.